CORT
Corcept Therapeutics Incorporated
Latest News for CORT
A class action lawsuit was filed against Corcept Therapeutics ($CORT) on February 20, 2026. Plaintiffs -shareholders- in the federal securities cla......
There’s a lot to be optimistic about in the NA sector as 2 analysts just weighed in on Ottobock SE & Co. KGaA (OBCKF) and Corcept Therapeutics (COR......
Corcept Therapeutics (CORT) told investors approval was on track through December 2025. Then the company disclosed that the FDA had issued a Comple......
The latest update is out from Corcept Therapeutics ( ($CORT) ). On March 25, 2026, Corcept Therapeutics announced U.S. FDA approval of Lifyorli (re......
The latest update is out from Corcept Therapeutics ( ($CORT) ). On March 25, 2026, Corcept Therapeutics announced U.S. FDA approval of Lifyorli (re......
Shares in biopharma company Corcept Therapeutics ($CORT) climbed as high as 48% to $48.35 following U.S. approval of Lifyorli for treating certain ......
Shares in biopharma company Corcept Therapeutics ($CORT) climbed as high as 48% to $48.35 following U.S. approval of Lifyorli for treating certain ......
Analysts have been eager to weigh in on the NA sector with new ratings on Corcept Therapeutics (CORT) and Fiserv (FISV). Corcept Therapeutics (CORT......
Analysts have been eager to weigh in on the NA sector with new ratings on Corcept Therapeutics (CORT) and Fiserv (FISV). Corcept Therapeutics (CORT......
Corcept Therapeutics ($CORT) told investors relacorilant was a promising next-generation treatment for hypercortisolism supported by clinical data ......
News data is sourced from MarketXLS API and updated regularly.
Showing 10 of 11 articles.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | CORT | $41.88 | +0.5% | 929.59K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Corcept Therapeutics Incorporated Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW